Ocular Therapeutix SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 16, 2026, 4:15 p.m. ETView on SEC.gov
Departure/appointment of directors or officers
AI summary, unreviewedOcular Therapeutix Chief Strategy Officer Sanjay Nayak Resigns Effective October 16, 2026 to Join Private Company
4Oct. 13, 2026, 5:01 p.m. ETView on SEC.gov
4Oct. 6, 2026, 4:44 p.m. ETView on SEC.gov
4Oct. 6, 2026, 4:43 p.m. ETView on SEC.gov
4Sept. 2, 2026, 4:01 p.m. ETView on SEC.gov
4Aug. 26, 2026, 5:59 p.m. ETView on SEC.gov
4Aug. 26, 2026, 5:58 p.m. ETView on SEC.gov
4Aug. 26, 2026, 5:57 p.m. ETView on SEC.gov
4Aug. 26, 2026, 5:56 p.m. ETView on SEC.gov
10-QAug. 3, 2026, 7:16 a.m. ETView on SEC.gov
8-KAug. 3, 2026, 7:07 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
SCHEDULE 13G/AJuly 29, 2026, 3:19 p.m. ETView on SEC.gov